In December 2022, FDA approved Sunlenca (Gilead Sciences, Inc.), the first medication in a new class of drugs used to treat HIV type 1 (HIV-1) in patients who are unable to be successfully treated with other available medications.
Lauren Howell, PharmD
With 77% of Americans taking at least one supplement on a regular basis, it is more important than ever for pharmacists to know about these products.
With a large amount of new, high-quality data available, the Kidney Disease: Improving Global Outcomes (KDIGO) workgroup issued a new comprehensive update on diabetes management in chronic kidney disease (CKD) only 2 short years after the last comprehensive update became available.
Ariel L. Clark, PharmD
At the start of 2023, the American College of Physicians (ACP) released an update to their pharmacological guideline recommendations for the treatment of osteoporosis and low bone mass to prevent fractures in adults.
Clarissa Chan, PharmD
For individuals with suicidal thoughts or who don’t respond to any therapies for depression, ketamine offers a treatment choice, according to Megan Ehret, PharmD, BCPP, from the University of Maryland School of Pharmacy.
Loren Bonner